Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review

被引:109
|
作者
Santacruz, Carlos A. [1 ]
Pereira, Adriano J. [2 ]
Celis, Edgar [1 ]
Vincent, Jean-Louis [3 ]
机构
[1] Acad Hosp Fdn Santa Fe Bogota, Dept Crit & Intens Care Med, Bogota, Colombia
[2] Hosp Israelita Albert Einstein, Dept Intens Care, Sao Paulo, Brazil
[3] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium
关键词
critically ill; heterogeneity; iatrogenicity; outcomes; process of care; RESPIRATORY-DISTRESS-SYNDROME; TUMOR-NECROSIS-FACTOR; VENTILATOR-ASSOCIATED PNEUMONIA; RENAL-REPLACEMENT THERAPY; END-EXPIRATORY PRESSURE; ACUTE KIDNEY INJURY; ACUTE LUNG INJURY; HUMAN MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; CONTINUOUS VENOVENOUS HEMODIAFILTRATION;
D O I
10.1097/CCM.0000000000004000
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To determine which multicenter randomized controlled trials in critically ill patients have shown that the study intervention was associated with a statistically significant reduction in mortality. Our analysis provides an update to a report published 10 years ago. Data Sources: MEDLINE database and PubMed interface from inception until April 30, 2019. Study Selection: All adult multicenter randomized controlled trials that evaluated the effects of any intervention or monitoring system in critically ill patients and reported mortality as a primary or secondary outcome were included. Data Extraction: Numbers of centers and patients, type of intervention, reported mortality outcome, and rate and level of significance were extracted into predefined tables. Included randomized controlled trials were classified as reporting reduced, increased, or no effect of the intervention on mortality. Methodologic quality of trials was evaluated using the updated Consolidated Standards of Reporting Trials statement. Data Synthesis: A total of 212 trials met the inclusion criteria: 27 (13%) reported a significant reduction in mortality, 16 (7%) an increase in mortality, and 170 (80%) no difference in mortality (one study was reported in 2 groups). Of the 27 trials reporting reduced mortality, six had assessed interventions likely to decrease ventilator-induced lung injury, including low tidal volume, prone position, and neuromuscular blockers, demonstrating the negative effects of mechanical ventilation strategies or improved process of care rather than positive effects of new therapies. Seven of the 27 trials reported beneficial effects of noninvasive ventilation. Results from some positive randomized controlled trials, for example, studies of recombinant activated protein C, talactoferrin, interleukin-1 receptor antagonist in sepsis, and muscle relaxants in severe acute respiratory distress syndrome were not replicated in subsequent randomized controlled trials. Other interventions, for example, gastric tonometry, have been abandoned. Conclusions: A systematic literature search provided no conclusive evidence of any pharmacologic intervention that has consistently reduced mortality in critically ill patients. Strategies associated with improved or noninvasive mechanical ventilation were associated with reduced mortality.
引用
收藏
页码:1680 / 1691
页数:12
相关论文
共 50 条
  • [1] Fragility Index in Multicenter Randomized Controlled Trials in Critical Care Medicine That Have Shown Reduced Mortality
    Vargas, Maria
    Buonano, Pasquale
    Marra, Annachiara
    Iacovazzo, Carmine
    Servillo, Giuseppe
    CRITICAL CARE MEDICINE, 2020, 48 (03) : E250 - E251
  • [2] Fragility Index in Multicenter Randomized Controlled Trials in Critical Care Medicine That Have Shown Reduced Mortality Reply
    Vincent, Jean-Louis
    Santacruz, Carlos A.
    CRITICAL CARE MEDICINE, 2020, 48 (03) : E251 - E251
  • [3] Eligibility Criteria of Randomized Controlled Trials in Critical Care Medicine: A Systematic Review
    Heybati, K.
    Heirali, A.
    Sereeyotin, J.
    Khan, F.
    Yarnell, C. J.
    Krewulak, K.
    Murthy, S.
    Burns, K. E.
    Fowler, R.
    Fiest, K.
    Mehta, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [4] Which therapeutic interventions in critical care medicine have been shown to reduce mortality in prospective, randomized, clinical trials? A survey of candidates for the Belgian Board Examination in Intensive Care Medicine
    Vincent, JL
    CRITICAL CARE MEDICINE, 2000, 28 (05) : 1616 - 1620
  • [5] Randomized controlled trials in critical care medicine
    Zijlstra, J. G.
    Ligtenberg, J. J. M.
    Girbes, A. R. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (01): : 43 - 43
  • [6] PILOT RANDOMIZED CONTROLLED TRIALS IN PEDIATRIC CRITICAL CARE: A SYSTEMATIC REVIEW
    Duffett, M.
    Choong, K.
    Cupido, C.
    Hartling, L.
    Menon, K.
    Thabane, L.
    Cook, D. J.
    INTENSIVE CARE MEDICINE, 2013, 39 : S54 - S54
  • [7] Understanding the Reproducibility of Randomized Controlled Trials in Critical Care: A Systematic Review
    Niven, D.
    McCormick, J.
    Barnes, T.
    Fiest, K.
    Straus, S.
    Hemmelgarn, B.
    Jeffs, L.
    Stelfox, H. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Rationale, Methodological Quality, and Reporting of Cluster-Randomized Controlled Trials in Critical Care Medicine: A Systematic Review
    Cook, David J.
    Rutherford, William B.
    Scales, Damon C.
    Adhikari, Neill K. J.
    Cuthbertson, Brian H.
    CRITICAL CARE MEDICINE, 2021, 49 (06) : 977 - 987
  • [9] The Fragility Index in Multicenter Randomized Controlled Critical Care Trials
    Ridgeon, Elliott E.
    Young, Paul J.
    Bellomo, Rinaldo
    Mucchetti, Marta
    Lembo, Rosalba
    Landoni, Giovanni
    CRITICAL CARE MEDICINE, 2016, 44 (07) : 1278 - 1284
  • [10] Multicenter randomized controlled trials in transfusion medicine
    Vamvakas, EC
    TRANSFUSION MEDICINE REVIEWS, 2000, 14 (02) : 137 - 150